Axogen Inc (STU:LT3)
€ 35.45 -2.67 (-7%) Market Cap: 1.89 Bil Enterprise Value: 1.82 Bil PE Ratio: 0 PB Ratio: 8.81 GF Score: 70/100

AxoGen Inc Annual Shareholders Meeting Transcript

Jun 23, 2026 / 12:30PM GMT
Release Date Price: €39.16 (+0.31%)
Michael Dale
AxoGen Inc - Chief Executive Officer, Director

Good morning, and welcome to the 2026 Annual Meeting of Shareholders of Axogen Incorporated. I'm Michael Dale, President, Chief Executive Officer, and a Director of Axogen. We are pleased to host this meeting virtually again this year, allowing broader participation from our shareholders.

Before we begin the formal portion of the meeting, I'd like to introduce the members of our Board of Directors: Paul Thomas, Chairman of the Board; William Burke, Chair of the Audit Committee; John Johnson, Chair of the Quality Compliance and Portfolio Management Committee; Amy Wendell, Chair of the Compensation Committee; Kathy Weiler, Chair of the Governance, Nominating, and Sustainability Committee; Alan Levine, and Joseph Tyndall.

We are also joined today by representatives from Deloitte & Touche, our independent registered public accounting firm; Morrison & Foerster, our outside legal counsel; Broadridge Financial Solutions, represented by [Christopher Woods], who is serving as the Inspector of Elections. And from Axogen's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot